ISV-120 DuraSite eyedrop formulation of batimastat: Began Phase II trial in 40 patients who have had surgery to remove a primary pterygium, to compare efficacy

InSite Vision Inc. (INSV), Alameda, Calif. Product: ISV-120 DuraSite eyedrop formulation of batimastat, an inhibitor of enzymes involved in abnormal tissue growth, licensed from British Biotech plc (...